Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 2
Results: 22
Corrigendum.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 304, doi. 10.1093/neuonc/nox015
- Publication type:
- Article
Comment on Hatzoglou et al: Dynamic contrastenhanced MRI perfusion versus <sup>18</sup>FDG PET/CT in differentiating brain tumor progression from radiation injury.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 300, doi. 10.1093/neuonc/now268
- By:
- Publication type:
- Article
Cognitive function, cerebral microbleeds, radiotherapy, and bevacizumab in survivors of pediatric brain tumors.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 298, doi. 10.1093/neuonc/now246
- By:
- Publication type:
- Article
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 289, doi. 10.1093/neuonc/now158
- By:
- Publication type:
- Article
Dynamic O-(2-<sup>18</sup>F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 281, doi. 10.1093/neuonc/now149
- By:
- Publication type:
- Article
Cancers of the brain and CNS: global patterns and trends in incidence.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 270, doi. 10.1093/neuonc/now166
- By:
- Publication type:
- Article
Adjuvant chemotherapy and overall survival in adult medulloblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 259, doi. 10.1093/neuonc/now150
- By:
- Publication type:
- Article
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 252, doi. 10.1093/neuonc/now236
- By:
- Publication type:
- Article
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 242, doi. 10.1093/neuonc/now176
- By:
- Publication type:
- Article
A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 229, doi. 10.1093/neuonc/now164
- By:
- Publication type:
- Article
Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 219, doi. 10.1093/neuonc/now160
- By:
- Publication type:
- Article
The complex role of transglutaminase 2 in glioblastoma proliferation.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 208, doi. 10.1093/neuonc/now157
- By:
- Publication type:
- Article
Meeting update--Society for Neuro-Oncology 2016 annual meeting.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 150, doi. 10.1093/neuonc/now295
- By:
- Publication type:
- Article
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and-resistant glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 186, doi. 10.1093/neuonc/now141
- By:
- Publication type:
- Article
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 175, doi. 10.1093/neuonc/now147
- By:
- Publication type:
- Article
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 162, doi. 10.1093/neuonc/now241
- By:
- Publication type:
- Article
Pediatric high-grade glioma: biologically and clinically in need of new thinking.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 153, doi. 10.1093/neuonc/now101
- By:
- Publication type:
- Article
Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 197, doi. 10.1093/neuonc/now174
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 147, doi. 10.1093/neuonc/now298
- By:
- Publication type:
- Article
Adjuvant nitrosoureas: will they ever go away?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 145, doi. 10.1093/neuonc/now268
- By:
- Publication type:
- Article
Controversies in management of low-grade gliomas in light of new data from clinical trials.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 143, doi. 10.1093/neuonc/now275
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. e1, doi. 10.1093/neuonc/nox004
- Publication type:
- Article